CASI Pharmaceuticals Inc
OTC:CASIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CASI Pharmaceuticals Inc
OTC:CASIF
|
CN |
|
A
|
ATC Venture Group Inc
OTC:ATCV
|
US |
|
Cellcom Israel Ltd
OTC:CELJF
|
IL |
|
I
|
Impact Analytics Inc
OTC:IPTNF
|
CA |
|
Targovax ASA
LSE:0RIS
|
NO |
|
Minco Silver Corp
OTC:MISVF
|
CA |
|
ECS Botanics Holdings Ltd
F:F1J
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CASIF's stock price target?
Not Available
CASIF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for CASI Pharmaceuticals Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 5 years is 9%.